Gene: At3g58880 (annotated as F-box2 in Arabidopsis)
Protein Function: Member of the F-box protein family, which facilitates substrate recognition in the ubiquitin-proteasome system .
Molecular Weight: ~35 kDa (predicted based on gene sequence) .
Derived from Arabidopsis thaliana (Mouse-ear cress).
A 2021 study using Arabidopsis amiRNA libraries identified At3g58880 as part of a functionally redundant gene set regulating ABA sensitivity during seed germination :
Experimental Design:
T2/T3 transgenic lines expressing amiRNAs targeting At3g58880 and homologous genes.
ABA concentrations: 0.5–3 μM.
Results:
| Phenotype | amiRNA Lines vs. Wild-Type (Col-0) |
|---|---|
| Cotyledon greening rate | 42% ↑ (p < 0.05) |
| RAB18 gene expression | 68% ↓ (ABA-induced) |
| Total viable seedlings | No significant difference |
Lines targeting At3g58880 showed reduced ABA-mediated inhibition of germination, suggesting its role in early stress response .
At3g58880 interacts with:
At3g58880 is a gene locus in Arabidopsis thaliana that encodes a specific protein of research interest. Antibodies targeting this protein are valuable for studying its expression, localization, and function in plant cellular processes. The significance of this gene stems from its potential role in plant developmental processes, stress responses, or other biological pathways that researchers aim to elucidate through immunological techniques. Understanding its function contributes to broader knowledge of plant biology and potentially agricultural applications. When designing experiments with this antibody, researchers should first establish the expression pattern of At3g58880 in their specific plant system to ensure appropriate experimental conditions .
At3g58880 Antibody can be utilized in various immunological applications common to research settings:
| Application | Recommended Dilution | Sample Preparation | Controls Needed |
|---|---|---|---|
| Western Blotting | 1:1000-1:2000 | Protein extraction in denaturing conditions | Positive control (known At3g58880 expressing tissue), negative control (knockout/knockdown) |
| Immunoprecipitation | 1:100-1:500 | Native protein extraction | Pre-immune serum control |
| Immunohistochemistry | 1:100-1:500 | Fixed tissue sections | Secondary antibody-only control |
| ELISA | 1:1000-1:5000 | Purified protein or crude extract | Standard curve with recombinant protein |
| ChIP | 1:50-1:200 | Cross-linked chromatin | IgG control, input control |
When designing experiments with this antibody, it's essential to optimize conditions for your specific application and tissue type. The experimental design should include appropriate controls to validate specificity and minimize background signal .
Proper storage and handling of At3g58880 Antibody are crucial for maintaining its binding capacity and specificity:
Store the antibody at -20°C for long-term storage and 4°C for short-term use (1-2 weeks)
Avoid repeated freeze-thaw cycles by aliquoting the antibody upon receipt
When preparing working dilutions, use sterile buffers (PBS or TBS) with a carrier protein (0.1-1% BSA)
For prolonged stability, consider adding preservatives such as sodium azide (0.02%) to storage solutions
Always centrifuge the antibody vial briefly before opening to collect contents at the bottom
Improper storage can lead to aggregation, denaturation, or contamination, compromising experimental results. Document the date of receipt, aliquoting, and experimental use to track antibody performance over time .
Understanding the specific epitope recognized by At3g58880 Antibody is crucial for interpreting experimental results and predicting potential cross-reactivity. Epitope mapping can be conducted through several complementary approaches:
Peptide Arrays: Synthesize overlapping peptides spanning the At3g58880 protein sequence and screen for antibody binding to identify the linear epitope region. This approach is particularly useful for antibodies recognizing linear epitopes rather than conformational ones.
Mutagenesis Analysis: Introduce point mutations or deletions in the target protein and assess antibody binding to identify critical residues involved in the interaction. This approach can reveal the structural basis of antibody recognition.
X-ray Crystallography: For high-resolution analysis, co-crystallize the antibody-antigen complex and determine the three-dimensional structure. This provides atomic-level details of the interaction interface, as demonstrated in similar antibody studies .
Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS): This technique can identify regions of the protein that are protected from solvent exchange upon antibody binding, indicating the epitope region.
The structural analysis of antibody-antigen complexes reveals that most antibodies recognize extended conformations of peptide antigens at their surface. Comparison with similar antibody structures can provide insights into epitope specificity and cross-reactivity potential .
Immunoprecipitation (IP) with At3g58880 Antibody may present challenges in terms of specificity and background. Advanced strategies to enhance IP performance include:
| Challenge | Advanced Solution | Methodological Rationale |
|---|---|---|
| High background | Pre-clear lysates with Protein A/G beads | Removes non-specific binding proteins before adding the specific antibody |
| Cross-reactivity | Cross-link antibody to beads | Prevents antibody leaching and contamination of samples with IgG |
| Low target abundance | Sequential IP (tandem IP) | Performs two consecutive IPs to increase specificity |
| Weak interactions | Optimize buffer conditions | Adjusts salt, detergent, and pH to maintain interactions while reducing non-specific binding |
| Post-translational modifications | Use phosphatase/protease inhibitors | Preserves the native state of the target protein |
For complex plant tissue samples, consider using nuclear fractionation or other subcellular fractionation techniques before IP to enrich for the cellular compartment where At3g58880 is predominantly localized. Validate IP results using reciprocal IP with known interaction partners and mass spectrometry analysis of immunoprecipitated complexes .
The three-dimensional structure of proteins significantly influences antibody binding. For At3g58880 protein:
Conformational Epitopes: If the antibody recognizes a conformational epitope (non-continuous amino acids brought together in the folded structure), denaturation during sample preparation can abolish antibody recognition.
Post-translational Modifications (PTMs): Phosphorylation, glycosylation, or other PTMs near the epitope region may sterically hinder antibody binding or create new recognition sites.
Protein-Protein Interactions: Binding of other proteins to At3g58880 may mask epitopes or induce allosteric changes affecting antibody recognition.
Environmental Factors: pH, ionic strength, and temperature can alter protein conformation and consequently antibody binding.
To address these issues, researchers should characterize the nature of the epitope (linear vs. conformational) using techniques such as Western blotting under reducing and non-reducing conditions. For studies requiring native protein recognition, use mild lysis conditions and native PAGE rather than denaturing SDS-PAGE. Structural biology techniques, similar to those used for other antibody-antigen complexes, can provide insights into recognition mechanisms .
Rigorous controls are essential for validating results obtained with At3g58880 Antibody:
Positive Controls:
Wild-type tissues known to express At3g58880
Recombinant At3g58880 protein (if available)
Transfected cells overexpressing At3g58880
Negative Controls:
Knockout/knockdown plants lacking At3g58880 expression
Tissues where At3g58880 is not expressed
Pre-immune serum or isotype control antibodies
Secondary antibody-only controls
Validation Controls:
Peptide competition assays where excess antigenic peptide blocks antibody binding
Multiple antibodies against different epitopes of At3g58880
Correlation of protein detection with mRNA expression
For quantitative applications, standard curves with purified recombinant protein should be included. In immunolocalization studies, co-staining with organelle markers helps confirm subcellular localization. These comprehensive controls help distinguish specific signals from artifacts and validate antibody specificity .
When commercial At3g58880 antibodies don't meet specific research needs, generating custom antibodies may be necessary:
| Strategy | Advantages | Limitations | Best Used For |
|---|---|---|---|
| Peptide Immunization | Target-specific epitopes, Good for isoform discrimination | May not recognize native protein | Western blotting, IHC of fixed tissues |
| Recombinant Protein Immunization | Recognition of multiple epitopes, Higher avidity | Potential cross-reactivity, More complex production | IP, ELISA, Flow cytometry |
| DNA Immunization | Native protein folding, PTMs maintained | Lower titer, Variable expression | Conformational epitopes, Membrane proteins |
| Monoclonal Development | Consistent renewable source, Highly specific | Time-consuming, Expensive | Long-term projects requiring standardization |
| Polyclonal Development | Recognizes multiple epitopes, Stronger signal | Batch-to-batch variation, Limited supply | Initial characterization, Signal amplification |
The choice of antigen design is critical. For At3g58880, bioinformatic analysis should identify unique regions that don't share homology with related proteins. Hydrophilic, surface-exposed regions make better antigens. Consider conjugating peptides to carrier proteins (KLH or BSA) to enhance immunogenicity .
Modern research often requires simultaneous detection of multiple proteins. For At3g58880 Antibody:
Fluorescence Multiplexing:
Use antibodies raised in different host species
Select fluorophores with minimal spectral overlap
Employ sequential staining protocols for antibodies from the same species
Consider tyramide signal amplification for low-abundance targets
Mass Cytometry Approaches:
Label antibodies with rare earth metals
Allows simultaneous detection of 40+ proteins without fluorescence spillover
Requires specialized equipment but provides high-dimensional data
Sequential Multiplexing:
Perform iterative rounds of staining, imaging, and antibody stripping
Enables virtually unlimited multiplexing capability
Requires careful validation of stripping efficiency
Barcoding Strategies:
For single-cell analysis, combine with DNA-barcoded antibodies
Enables high-throughput screening with sequencing readout
When designing multiplexed experiments, start with validation of each antibody individually before combining them. Cross-reactivity between secondary antibodies must be rigorously tested. The choice of multiplexing strategy should align with research questions and available instrumentation .
Plant tissues present unique challenges for antibody applications due to their complex matrices:
Sample Preparation Optimization:
Include reducing agents (DTT, β-mercaptoethanol) to break disulfide bonds
Add plant-specific protease inhibitors (e.g., PMSF, leupeptin, pepstatin)
Use PVPP (polyvinylpolypyrrolidone) to remove phenolic compounds
Consider fractionation to enrich for cellular compartments of interest
Blocking Optimization:
Test different blocking agents (BSA, milk, fish gelatin, plant-derived blockers)
Increase blocking time and concentration for high-background samples
Include 0.1-0.3% Triton X-100 to reduce hydrophobic interactions
Antibody Incubation Conditions:
Optimize antibody dilution (typically start with 1:500-1:2000 range)
Extend incubation time at 4°C (overnight) with gentle agitation
Add 0.05-0.1% Tween-20 to reduce non-specific interactions
Washing Optimization:
Increase number and duration of washes
Use buffers with appropriate ionic strength (150-300 mM NaCl)
Include 0.1% detergent in wash buffers
Systematic optimization of these parameters should be documented to establish reproducible protocols for At3g58880 detection in specific plant tissue contexts .
Quantitative analysis of immunoblotting, ELISA, or immunohistochemistry data requires appropriate statistical treatment:
Normalization Strategies:
Use housekeeping proteins (tubulin, actin) as loading controls
Consider global normalization methods for large-scale proteomics
Employ spike-in standards for absolute quantification
Statistical Tests:
For comparing two conditions: Student's t-test or Mann-Whitney U test
For multiple conditions: ANOVA with appropriate post-hoc tests
For correlation analysis: Pearson or Spearman correlation coefficients
Addressing Variability:
Perform biological replicates (different plants/samples)
Include technical replicates to assess method variability
Calculate coefficient of variation to assess reproducibility
Presentation Guidelines:
Report means with standard deviation or standard error
Use box plots or violin plots to show distribution of data
Include individual data points for transparency
To ensure validity, power analysis should be performed to determine appropriate sample sizes. For complex experimental designs, consider consulting with a statistician to select the most appropriate statistical approach .
Researchers sometimes encounter discrepancies when using the same antibody across different applications:
Method-Specific Epitope Accessibility:
Western blotting detects denatured proteins while IP requires native conformation
Fixation methods in immunohistochemistry can mask or expose different epitopes
ELISA may detect solution-accessible epitopes not available in tissue sections
Resolution of Contradictions:
Perform epitope mapping to understand antibody recognition requirements
Use orthogonal methods (e.g., mass spectrometry) to confirm protein identity
Compare results with mRNA expression data (qPCR, RNA-seq)
Test multiple antibodies targeting different regions of At3g58880
Technical Validation:
Verify antibody specificity in each application independently
Consider post-translational modifications that might affect recognition
Examine experimental conditions that might affect protein conformation
Biological Explanations:
Investigate potential splice variants or isoforms
Consider protein degradation or processing in different contexts
Examine subcellular localization differences between tissues/conditions
When publishing results, transparently report any method-specific differences and provide potential explanations based on the biology of At3g58880 and technical limitations of each method .
Computational methods offer powerful tools for antibody development and characterization:
Structural Prediction:
Use AlphaFold or RoseTTAFold to predict At3g58880 protein structure
Calculate surface accessibility to identify exposed regions
Simulate antibody-antigen docking to predict binding interfaces
Epitope Prediction Algorithms:
B-cell epitope prediction tools (BepiPred, Ellipro)
Antigenicity scales (Hopp-Woods, Kyte-Doolittle)
Machine learning approaches integrating multiple parameters
Cross-Reactivity Assessment:
BLAST searches against proteome to identify potential cross-reactive proteins
Structural alignment of homologous proteins to identify conserved surfaces
Assessment of epitope conservation across species for cross-species applications
When designing new antibodies against At3g58880, these computational approaches can guide selection of optimal antigenic regions, potentially improving specificity and functionality of the resulting antibodies .
Recent technological advances offer new possibilities for antibody-based detection:
Proximity Ligation Assay (PLA):
Detects protein-protein interactions with single-molecule sensitivity
Combines antibody recognition with DNA amplification
Useful for detecting low-abundance At3g58880 interactions in situ
Super-Resolution Microscopy:
STORM, PALM, or STED microscopy for nanoscale localization
Requires high-quality antibodies with minimal background
Can resolve subcellular distribution beyond diffraction limit
Single-Cell Proteomics:
Mass cytometry (CyTOF) for multiplexed protein detection
Microfluidic antibody-based single-cell analysis
Enables correlation of At3g58880 expression with cellular heterogeneity
Engineered Antibody Formats:
Single-chain variable fragments (scFvs) for improved tissue penetration
Nanobodies derived from camelid antibodies for smaller size
Bispecific antibodies for simultaneous detection of At3g58880 and interacting partners
These technologies can be particularly valuable for investigating low-abundance proteins or visualizing protein interactions in complex tissues .
Applying antibodies across species requires careful validation:
Sequence Homology Analysis:
Align At3g58880 sequences across plant species of interest
Calculate percent identity in the epitope region
Predict conservation of tertiary structure around the epitope
Experimental Validation Pipeline:
Test antibody against recombinant proteins from each species
Perform Western blotting with positive and negative controls for each species
Validate using genetic approaches (knockouts/knockdowns) when available
Optimization for Cross-Species Application:
Adjust antibody concentration for different species
Modify sample preparation protocols for species-specific tissues
Consider species-specific blocking reagents to reduce background
Documentation of Cross-Reactivity:
Create a detailed validation report for each species tested
Document any species-specific detection conditions
Note limitations in cross-species applications
This systematic approach ensures reliable interpretation of results when studying At3g58880 homologs across multiple plant species, contributing to comparative plant biology research .